PESARINI, Gabriele
 Distribuzione geografica
Continente #
EU - Europa 4.616
NA - Nord America 3.224
AS - Asia 2.812
SA - Sud America 375
AF - Africa 95
OC - Oceania 7
Totale 11.129
Nazione #
US - Stati Uniti d'America 3.139
RU - Federazione Russa 2.146
SG - Singapore 1.094
CN - Cina 951
GB - Regno Unito 868
IT - Italia 362
BR - Brasile 308
HK - Hong Kong 304
DE - Germania 241
FR - Francia 236
SE - Svezia 225
IE - Irlanda 186
FI - Finlandia 181
VN - Vietnam 147
KR - Corea 107
CA - Canada 40
UA - Ucraina 37
IN - India 34
TG - Togo 30
ID - Indonesia 29
MX - Messico 29
JP - Giappone 24
ZA - Sudafrica 24
AR - Argentina 21
BJ - Benin 21
TR - Turchia 21
BE - Belgio 19
NL - Olanda 19
PL - Polonia 18
ES - Italia 16
CO - Colombia 12
BD - Bangladesh 11
IQ - Iraq 11
IR - Iran 11
MA - Marocco 11
AT - Austria 10
EC - Ecuador 10
LT - Lituania 10
VE - Venezuela 9
KG - Kirghizistan 8
PK - Pakistan 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
IL - Israele 7
CH - Svizzera 6
CL - Cile 5
HU - Ungheria 4
PE - Perù 4
PT - Portogallo 4
UZ - Uzbekistan 4
AL - Albania 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
JO - Giordania 3
KZ - Kazakistan 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
RO - Romania 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
AU - Australia 2
BH - Bahrain 2
BZ - Belize 2
GT - Guatemala 2
JM - Giamaica 2
KE - Kenya 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
PY - Paraguay 2
SI - Slovenia 2
TJ - Tagikistan 2
BY - Bielorussia 1
CD - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KI - Kiribati 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MZ - Mozambico 1
NC - Nuova Caledonia 1
NG - Nigeria 1
PH - Filippine 1
RE - Reunion 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TL - Timor Orientale 1
TN - Tunisia 1
Totale 11.129
Città #
Moscow 763
Southend 742
Singapore 408
Dallas 393
Chandler 368
Ashburn 361
Hong Kong 303
Jacksonville 224
Beijing 208
Dublin 184
New York 156
Munich 97
Woodbridge 96
Los Angeles 94
Helsinki 93
Ann Arbor 82
Verona 82
Houston 70
Jinan 66
Lawrence 58
Princeton 58
Ho Chi Minh City 55
The Dalles 54
Wilmington 52
Shenyang 49
Nanjing 37
Redondo Beach 37
Santa Clara 36
Tianjin 36
São Paulo 35
Buffalo 34
Hebei 34
Milan 34
London 33
Turku 32
Hanoi 30
Lomé 30
Seattle 30
Seoul 28
Columbus 26
Sindelfingen 26
Nanchang 23
Taizhou 23
Zhengzhou 23
Changsha 22
Denver 22
Frankfurt am Main 22
Cedar Knolls 21
Cotonou 21
Tokyo 21
Haikou 20
Brussels 19
Brooklyn 18
Johannesburg 18
Montreal 18
Rome 18
Taiyuan 18
Ningbo 17
Phoenix 17
Washington 17
Chennai 16
Falkenstein 16
Kent 16
Stockholm 16
Hangzhou 15
Jakarta 15
Poplar 14
Toronto 14
Warsaw 14
Guangzhou 13
Nuremberg 13
Redwood City 13
Amsterdam 12
Boston 12
Jiaxing 12
San Francisco 12
Atlanta 11
Fairfield 11
Lappeenranta 11
Norwalk 11
Fuzhou 10
Lanzhou 10
Mexico City 10
Rio de Janeiro 10
Belo Horizonte 9
Brasília 9
Querétaro 9
Chicago 8
Lancaster 8
Orem 8
Shanghai 8
Ankara 7
Bishkek 7
Biên Hòa 7
Council Bluffs 7
Curitiba 7
Da Nang 7
Manchester 7
Turin 7
Vienna 7
Totale 6.441
Nome #
Clinical outcomes of transcatheter aortic valve implantation: from learning curve to proficiency 559
MODULAZIONE DELLA RISPOSTA INFIAMMATORIA NELLA PREVENZIONE DELLA RESTENOSI POST STENT CORONARICO: IL TRIAL CLINICO MULTICENTRICO RANDOMIZZATO “CEREA-DES” 181
Long-Term (3 Years) Prognosis of Contrast-Induced Acute Kidney Injury After Coronary Angiography 170
"Valve in valve" implantation of two self-expandable transcatheter aortic valves in a patient with aortic root aneurysm and massive aortic regurgitation: "a new TAVI option" 167
Coronary Catheterization and Percutaneous Interventions After Transcatheter Aortic Valve Implantation 165
Contrast-Induced Acute Kidney Injury in Patients Undergoing TAVI Compared With Coronary Interventions 160
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 159
"Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy" 157
Hemodynamic predictors of long term survival in end stage cystic fibrosis 155
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale. 153
Immediate and long-term clinical performance of bioresorbable vascular scaffolds in a real world population 150
Correlation between intracoronary physiology and myocardial perfusion imaging in patients with severe aortic stenosis 149
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 146
Comparative Prognostic Value of Parameters of Pulsatile Right Ventricular Afterload in Patients With Advanced Heart Failure Awaiting Heart Transplantation 144
Physiologic Evaluation of Coronary Lesions Using Instantaneous Wave-free Ratio (iFR) in Patients with Severe Aortic Stenosis Undergoing Trans-catheter Aortic Valve Implantation 143
Effectiveness and Safety of Transcatheter Aortic Valve Implantation in Patients With Pure Aortic Regurgitation and Advanced Heart Failure 142
Transcatheter valve-in-mitral homograft in tricuspid position: first-in-man report 142
Coronary physiology in patients with severe aortic stenosis: Comparison between fractional flow reserve and instantaneous wave-free ratio 138
Functional Assessment of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation Influence of Pressure Overload on the Evaluation of Lesions Severity 136
Observations from a real-time, iFR-FFR "hybrid approach" in patients with severe aortic stenosis and coronary artery disease undergoing TAVI 133
iFR-FFR comparison in daily practice: a single-center, prospective, online assessment 131
Angiography-Derived Index of Microcirculatory Resistance to Define the Risk of Early Discharge in STEMI 130
Physiological Versus Angiographic Guidance for Myocardial Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation 130
The Activated Clotting Time Paradox: Relationship Between Activated Clotting Time and Occlusion of the Radial Artery When Used as Vascular Access for Percutaneous Coronary Procedures 130
Contrast-Induced Nephropathy in Patients Undergoing Staged Versus Concomitant Transcatheter Aortic Valve Implantation and Coronary Procedures 129
Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial. 129
Intravascular ultrasound assessment of coronary ostia following valve in valve transcatheter aortic valve implantation 129
Acute electrocardiographic differences between Takotsubo cardiomyopathy and anterior ST elevation myocardial infarction 128
Devices for mechanical circulatory support and strategies for their management in cardiogenic shock 126
Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans. 125
Coronary artery disease in patients undergoing transcatheter aortic valve implantation. A single centre registry on prevalence, management and immediate clinical impact 125
Clinical outcome after endovascular, surgical or hybrid revascularisation in patients with combined carotid and coronary artery disease: the Finalised Research In ENDovascular Strategies Study Group (FRIENDS). 124
Impella-protected PCI: the clinical results achieved so far 124
Comparison of the long-term survival benefits associated with revascularization or medical therapy in patients with known coronary artery disease undergoing transesophageal atrial pacing stress echocardiography 123
Impact of physiologically diffuse versus focal pattern of coronary disease on quantitative flow reserve diagnostic accuracy 121
Late and very late coronary stent thrombosis: Intravascular ultrasound findings and associations with antiplatelet therapy 119
New-onset extreme right axis deviation in acute myocardial infarction: clinical characteristics and outcomes 119
Long-term follow-up after trans-catheter tricuspid valve-in-valve replacement with balloon-expandable aortic valves 118
Early small creatinine shift predicts contrast-induced acute kidney injury and persistent renal damage after percutaneous coronary procedures 118
Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI 118
Proof of concept study on coronary microvascular function in low flow low gradient aortic stenosis 115
Angiography-derived index of microvascular resistance in takotsubo syndrome 115
Risk stratification in acute coronary syndromes. 114
Long-term variations of FFR and iFR after transcatheter aortic valve implantation 112
Early and long-term outcomes after combined percutaneous revascularization in patients with carotid and coronary artery stenoses. 110
Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation 109
Extravalvular Cardiac Damage and Renal Function Following Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis 109
Transapical mitral valve-in-valve procedure with elective venoarterial ECMO in a patient with severe kyphoscoliosis 108
Characterisation of coronary microvascular dysfunction in patients with severe aortic stenosis undergoing TAVI 105
First Observation of a "Golden Tube" After Complete Resorption of a Bioresorbable Vascular Scaffold in a Transplanted Patient With Cardiac Allograft Vasculopathy 105
Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation 105
Early shifts in serum creatinine concentrations can predict contrast-induced nephropathy and persistent renal damage following angiography,Modificazioni precoci nella concentrazione della creatininemia sono in grado di predire la nefropatia da mezzo di contrasto e il danno renale persistente dopo angiografia 101
Functional Patterns of Coronary Disease: Diffuse, Focal, and Serial Lesions 100
Cardiovascular imaging in arrhythmogenic right ventricular dysplasia/cardiomyopathy 98
Repeat revascularization: Percutaneous coronary intervention after coronary artery bypass graft surgery 98
Dynamic changes of repolarization abnormalities in takotsubo cardiomyopathy 98
Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes 95
Choosing transcatheter aortic valve replacement in porcelain aorta: outcomes versus surgical replacement 94
Bail-out transcatheter aortic valve implantation to reduce severe acute aortic regurgitation in a failing homograft secondary to HeartMate II ventricular assistance device 93
Percutaneous Impella Recover circulatory support in high-risk coronary angioplasty. 93
Glucocorticoids in the prevention of restenosis after coronary angioplasty: therapeutic potential. 93
Intraventricular entrapment of a Sapien-3 balloon in transapical TAVR: A near missed catastrophe 92
Long-term intracoronary imaging and physiological measurements of bioresorbable scaffolds and untreated atherosclerotic plaques 90
Steroid-eluting stents in patients with acute coronary syndromes. Angiographic results of DESIRE: Dexamethasone-Eluting Stent Italian REgistry. 89
Long-Term Outcomes of Coronary and Carotid Artery Disease Revascularization in the FRIENDS Study 89
Clinical Updates in Coronary Artery Disease: A Comprehensive Review 88
Recurrent very late drug-eluting stent thrombosis. 87
Osteomyelitis of the clavicle following to a pacemaker implantation 86
Vascular complications after transcatheter aortic valve implantation: treatment modalities and long-term clinical impact 85
Coronary obstruction after transcatheter aortic valve replacement combined with basilica procedure 84
Functional Patterns of Coronary Disease: Diffuse, Focal, and Serial Lesions 84
Transapical Transcatheter Aortic Valve Replacement: A Real-World Early and Mid-Term Outcome of a Third-Level Centre 84
Letter by Ribichini et al regarding article, "Cystatin C and contrast-induced acute kidney injury". 83
Radial artery occlusion after transradial procedures: impact on 1-year adverse events 82
Single-side renal sympathetic denervation to treat malignant refractory hypertension in a solitary kidney patient 81
Hemodynamics and its predictors during Impella-protected PCI in high risk patients with reduced ejection fraction 81
Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience 78
Radial artery occlusion after conventional and distal radial access: Impact of preserved flow and time-to-hemostasis in a propensity-score matching analysis of 1163 patients 77
Right Ventricle Pulmonary Artery Coupling and Renal Function in Patients With Severe Aortic Stenosis Undergoing TAVR 75
Long-term clinical follow-up of the multicentre, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminAte Restenosis (CEREA-DES) 74
Incomplete functional revascularization is associated with adverse clinical outcomes after transcatheter aortic valve implantation 74
Quality of Life after Transcatheter Aortic Valve Replacement in Sarcopenic Patients Using the Toronto Aortic Stenosis Quality of Life Questionnaire 73
Predictors of patent and occlusive hemostasis after transradial coronary procedures 73
Early Postoperative Thrombosis of Transcatheter Aortic Valve-in-Valve Prosthesis 70
Transcatheter tricuspid valve implantation by femoral approach in trivalvular heart disease 70
Transcatheter edge-to-edge mitral valve repair: what is the measure of success? 70
Is transfemoral aortic valve implantation possible without contrast medium in patients with renal and multiorgan failure? 67
Early and late clinical outcomes of endovascular, surgical, and hybrid revascularization strategies of combined carotid and coronary artery diseases: the FRIENDS study group (Finalized Research In ENDovascular Strategies) 67
Short-and-Long-Term Outcomes after Coronary Rotational Atherectomy in Patients Treated with Trans-Catheter Aortic Valve Implantation 67
Current Antithrombotic Therapy in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Interventions 66
Influence of physiological patterns of coronary disease on fractional flow reserve and instantaneous wave-free ratio changes in patients undergoing TAVI 64
Ten-Year Experience with Endomyocardial Biopsy after Orthotopic Heart Transplantation: Comparison between Trans-Jugular and Trans-Femoral Approach 64
Safety and efficacy of everolimus-eluting bioresorbable vascular scaffold for cardiac allograft vasculopathy (CART) 63
Predictors and Prognostic Impact of Left Ventricular Ejection Fraction Recovery after Impella-Supported Percutaneous Coronary Interventions in Acute Myocardial Infarction 63
The promise of vascular reparative therapy in standby mode. How long before a final decision? Complete vessel wall regeneration and vascular scaffold resorption after left anterior descending reconstructions 63
Integrated Assessment of Computational Coronary Physiology From a Single Angiographic View in Patients Undergoing TAVI 62
Transfemoral Edwards-Novaflex valve implantation in a patient with aorto-iliac endoprosthesis and severely tortuous bilateral external iliac arteries-"Railing track" 59
Ten-year experience with a transapical approach for transcatheter aortic and mitral valve implantation 59
Significant Drop in Right Atrial Pressure Does Not Influence Fractional Flow Reserve Coronary Assessment 56
The Influence of Aortic Valve Obstruction on the Hyperemic Intracoronary Physiology: Difference Between Resting Pd/Pa and FFR in Aortic Stenosis 55
Totale 11.009
Categoria #
all - tutte 44.547
article - articoli 44.118
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 429
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.094


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021316 0 0 0 0 92 62 15 19 22 51 47 8
2021/2022431 47 117 5 41 7 5 2 19 16 11 53 108
2022/20231.221 68 179 103 156 92 289 49 68 150 13 36 18
2023/20241.013 22 58 77 125 99 227 48 84 10 69 157 37
2024/20252.325 104 117 103 395 163 113 75 106 369 178 190 412
2025/20264.247 466 278 432 1.318 1.753 0 0 0 0 0 0 0
Totale 11.244